Pegfilgrastim vs filgrastim

Filgrastim Firmagon Floxuridine Fludarabine Fludara Pegfilgrastim Pegfilgrastim On-Pro Peginterferon Alfa-2b Pemazyre

by N Lathia 2024 Cited by 47pegfilgrastim vs no primary prophylaxis, and pegfilgrastim vs filgrastim. filgrastim versus filgrastim primary prophylaxis in women

During Consolidation, nonprophylactic anti-infective use was higher in the pegfilgrastim (82%) versus the filgrastim (67%) group. However, the median (interquartile range) duration of use was similar in the two groups (pegfilgrastim 21 (20, 33) vs filgrastim 21.5 (18, 35.5) days). The incidence and duration of hospitalization was similar in the

However, as the authors highlight, there are also claims for superiority of pegfilgrastim over filgrastim, which has led to considerable debate over the equivalence of filgrastim and pegfilgrastim. Current clinical guidelines in both Europe and the US assume that filgrastim and pegfilgrastim are clinically equivalent [3, 4].

Three patients received both pegfilgrastim and filgrastim during BEP treatment. One patient received both pegfilgrastim and filgrastim in the same cycle. In total, pegfilgrastim and filgrastim were administered in cycles, respectively. The median age at GCT diagnosis was 40.5 years.

Pegfilgrastim has a lower absolute bioavailability than filgrastim following subcutaneous administration. The absorption of pegfilgrastim is largely dependent

Compare Filgrastim vs Pegfilgrastim head-to-head with other drugs for uses, ratings, cost, side effects and interactions.

Filgrastim Firmagon Floxuridine Fludarabine Fludara Fluorodeoxyuridine Pegfilgrastim Pegfilgrastim On-Pro Peginterferon Alfa-2b Pemazyre

Other treatment-related adverse events including arthralgia (1.7 vs 6%), back pain (6.9 vs 3%) and headache (1.7 vs 6%) were reported for pegfilgrastim vs filgrastim.